Arkolith/Insider Trading/CANO/Form 4

Kent Mark D.

Interim CEO, DirectorCano Health, Inc. (CANO) · full profile →Form 4 · filed Jul 2, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 28, 2024Disposed to issuer(D)2K——0
Jun 28, 2024Disposed to issuer(D)46K——0
Jun 28, 2024Disposed to issuer(D)24K——0
Jun 28, 2024Disposed to issuer(D)24K——0
Jun 28, 2024Disposed to issuer(D)2K——0
Jun 28, 2024Disposed to issuer(D)15K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 28, 2024Grant(A)94K——94K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-080518) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML